Edition:
India

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

5.77USD
16 Feb 2018
Change (% chg)

$0.25 (+4.53%)
Prev Close
$5.52
Open
$5.47
Day's High
$6.20
Day's Low
$5.47
Volume
15,178
Avg. Vol
30,490
52-wk High
$15.19
52-wk Low
$4.84

Chart for

About

Arcturus Therapeutics Ltd, formerly Alcobra Ltd, is an Israel-based preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of ribonucleic acid (RNA) medicines using lipid-mediated nanoparticle delivery system (LUNAR) and Unlocked Nucleomonomer Agent (UNA) Oligomer... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $28.94
Shares Outstanding(Mil.): 27.56
Dividend: --
Yield (%): --

Financials

BRIEF-Arcturus Therapeutics Comments On Amended 13D Filing

* ARCTURUS THERAPEUTICS LTD - COMMENTED ON AMENDED 13D FILING BY JOSEPH E. PAYNE

16 Feb 2018

BRIEF-Joseph Payne Reports 13.7 Pct Stake In Arcturus Therapeutics

* JOSEPH PAYNE SAYS EMAILED LETTER DATED FEBRUARY 12, REQUESTED BOARD OF ARCTURUS THERAPEUTICS CONVENE EXTRAORDINARY GENERAL MEETING AS SOON AS POSSIBLE

13 Feb 2018

BRIEF-Certain Arcturus Therapeutics Shareholders Expressed Support For Former CEO Joseph Payne's Leadership

* FORMER CEO JOSEPH PAYNE SAYS HE WAS APPROACHED BY CERTAIN ARCTURUS THERAPEUTICS SHAREHOLDERS, WHO EXPRESSED SUPPORT FOR HIS CONTINUED LEADERSHIP

07 Feb 2018

BRIEF-Arcturus Therapeutics Appoints Mark Herbert As Interim President

* ARCTURUS THERAPEUTICS APPOINTS MARK HERBERT AS INTERIM PRESIDENT

02 Feb 2018

BRIEF-Bradley Thomas Sorenson Reports 5.6 Pct Stake In Arcturus Therapeutics As Of Nov. 16, 2017

* BRADLEY THOMAS SORENSON REPORTS 5.6 PERCENT STAKE IN ARCTURUS THERAPEUTICS LTD AS OF NOVEMBER 16, 2017 - SEC FILING

19 Jan 2018

BRIEF-Arcturus and Curevac Enter Into Strategic Collaboration To Jointly Novel Messenger RNA Therapeutics

* CO, CUREVAC AG ENTER INTO STRATEGIC COLLABORATION TO JOINTLY DISCOVER, DEVELOP,COMMERCIALIZE NOVEL MESSENGER RNA THERAPEUTICS

04 Jan 2018

BRIEF-Arcturus Therapeutics Ltd Says Raised About $67.8 Million In Equity Financing

* ARCTURUS THERAPEUTICS LTD SAYS RAISED ABOUT $67.8 MILLION IN EQUITY FINANCING Source text for Eikon: (http://bit.ly/2qp3QZW) Further company coverage:

04 Jan 2018

Earnings vs. Estimates